Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus
Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the novel oral anticoagulant apixaban with the
standard therapy of warfarin on the size reduction or resolution of left ventricular thrombus
over 3 months.
Phase:
Phase 3
Details
Lead Sponsor:
Universiti Sains Malaysia University of Science Malaysia